# OnCo record hair-loss-and-scalp-cooling-breast (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/hair-loss-and-scalp-cooling-breast/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "hair-loss-and-scalp-cooling-breast" ;
  schema:name "Hair loss and scalp cooling with breast cancer chemotherapy"@en ;
  schema:alternateName "chemotherapy hair loss"@en, "cold cap"@en ;
  schema:description "Taxane and anthracycline chemotherapy for triple-negative breast cancer causes hair loss in most people, usually starting after the first or second cycle and almost always growing back; scalp cooling kept more than half the hair in about half of women in a randomised trial and is offered in many UK units."@en ;
  schema:url <https://onco.cc/terms/hair-loss-and-scalp-cooling-breast/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2016.20939>, <https://doi.org/10.1001/jama.2016.21038>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/hair-loss>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/sacituzumab-govitecan> ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/scalp-cooling/> ;
  onco:drugs <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/epirubicin/>, <https://onco.cc/drugs/sacituzumab-govitecan/> .
